Medical Oncology· Topic 12.5 Cancers of the skin, bone, and soft tissue· 12.5.12

Soft tissue sarcoma

Soft tissue sarcoma is a diverse group of mesenchymal malignancies of fat, muscle, nerve, vessel, and fibrous tissue, confirmed only by biopsy and staged mainly by histologic grade and hematogenous (usually pulmonary) spread. A mass 5 cm or larger, deep to fascia, fixed, rapidly enlarging, recurrent, or painful without explanation should be imaged and biopsied before any excision.

8 min read1 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    A family of mesenchymal malignancies, not one disease: soft tissue sarcoma (STS) arises from fat (liposarcoma), smooth muscle (leiomyosarcoma), striated muscle (rhabdomyosarcoma), fibrous/dermal…

  • Epidemiology

    Age and histology split by life stage: rhabdomyosarcoma is the most common soft tissue sarcoma in children; liposarcoma and leiomyosarcoma predominate in adults.

  • Risk factors

    Li-Fraumeni syndrome (germline TP53, autosomal dominant): soft tissue and bone sarcomas, leukemia, breast cancer, brain tumors, and adrenocortical carcinoma; a confirmed carrier begins annual breast…

  • Pathophysiology

    Tissue-specific histogenesis: each subtype mirrors its cell of origin, for example smooth muscle to leiomyosarcoma, striated muscle to rhabdomyosarcoma, fat to liposarcoma, endothelium to…

  • Clinical features

    A firm, enlarging soft tissue mass is typical, and any mass with a red-flag feature should be evaluated as possible sarcoma rather than observed: 5 cm or larger, deep to fascia, rapidly enlarging…

  • Differential diagnosis

    Lipoma: the most common mimic; soft, freely mobile, painless, superficial, lacking the red-flag features above.

  • Diagnosis

    Diagnosis is established by histopathology, not clinical criteria: biopsy assigns histologic subtype (morphology and immunohistochemistry) and grade (differentiation and mitotic activity, low-grade…

  • Management

    First, refer any biopsy-confirmed or strongly suspected sarcoma to a multidisciplinary team (surgical oncology, radiation oncology, medical oncology) before treatment, since outcomes depend on coordinated planning around the biopsy tract.

  • Complications

    Local recurrence, particularly after an unplanned excisional biopsy or incomplete resection that contaminated surrounding tissue planes.

  • Prognosis

    Histologic grade and stage (local extent, nodal spread, and especially distant metastasis) together determine outcome, with stage generally carrying more prognostic weight than grade, since…

  • Prevention

    There is no general-population screening test for sporadic soft tissue sarcoma; prevention rests on recognizing red-flag features early (5 cm or larger, deep to fascia, fixed, rapidly enlarging…

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.